• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    MetLife Launches Cancer Support Benefit to Help Employees Understand and Navigate Care Options as Cancer Diagnoses Continue to Rise

    9/4/25 9:00:00 AM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email

    Through a strategic collaboration with Private Health Management, new offering provides individuals with expert-guided cancer education and financial support

    MetLife has introduced a new Cancer Support benefit to help employees with personalized advice and attention from diagnosis to treatment and through recovery. Through a strategic relationship with Private Health Management, a leader in complex care navigation, MetLife will expand its Critical Illness Insurance offering to provide a more robust cancer benefit, including access to top oncology specialists, tech-enabled and expert-led coordination, and patient counseling – all of which help to provide a clearer path forward for patients. This announcement comes as new cases of cancer are anticipated to rise to more than two million in 2025.1

    "Our new Cancer Support benefit raises the bar in delivering compassionate, expert-led guidance at a time when individuals are facing one of life's most difficult moments," said Chris Swanker, senior vice president, Group Benefits Products at MetLife. "For employers, it's a meaningful way to support their employees, offering a benefit that can make a difference in how they navigate the complexities of a cancer diagnosis and improve patient outcomes. As cancer costs continue to rise, this benefit also has been proven to reduce overall medical costs for employees and employers alike."

    One in every three Americans will develop cancer in their lifetime,1 and those impacted by cancer are 71% more likely to face financial hardship within two years of diagnosis.2 Cancer is one of the most expensive medical conditions to treat, with total costs projected to rise 34% between 2015 and 2030.2

    As part of the collaboration, Private Health Management's team of experienced professionals will work closely with MetLife to ensure that covered policyholders receive individualized counseling and attention, helping them navigate the complexities of cancer treatment and recovery. Employers who have deployed Private Health Management services have seen strong outcomes,3 including:

    - 20% reduction in average cost per case managed

    - 15% avoided unnecessary treatments

    - 30% received redefined/changed diagnoses

    - 70% saw modification of treatment plans for optimal care

    - 2-4 times improvement in survival for late-stage cancers

    "MetLife is building a truly comprehensive benefits experience – adding a Cancer Support benefit will be a critical element," said Ken Tarkoff, CEO of Private Health Management. "At Private Health Management, our mission is to empower patients with the knowledge, resources, and support they need to achieve the best possible outcomes. We are excited to team up with MetLife to bring that promise to more patients in their cancer treatment and recovery journeys."

    MetLife's Cancer Support benefit will be available to MetLife Critical Illness insureds with covered cancer conditions, beginning January 1, 2026. To learn more about MetLife's Critical Illness Insurance and Cancer Support benefit, visit our website or email directly.

    About MetLife

    MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.

    About PHM

    Private Health Management (PHM) is a clinically sophisticated complex care management company that provides guidance for individuals facing serious medical conditions like cancer. PHM connects clients with top specialists, cutting-edge diagnostics, and personalized, science-backed treatment plans to achieve the best possible care. Independent and trusted by leading employers and providers alike, PHM helps individuals make confident decisions that lead to better outcomes. Learn more at www.privatehealth.com.

    Citations:

    1. American Cancer Society, "Cancer Facts & Figures 2025," 2025. Cancer Facts & Figures 2025
    2. NIHCM Foundation, "Insights on Cancer: Rates, Costs, and Strategies" December 2024. Insights on Cancer: Rates, Costs, and Strategies
    3. Private Health Management. (2025, January). Improving cancer survival: PHM's impact on cancer care

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250904488273/en/

    Media Contact:

    Liz Harish

    929-343-7473

    [email protected]

    Get the next $MET alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    1/6/2026$97.00Outperform → In-line
    Evercore ISI
    12/16/2025$101.00Outperform
    Mizuho
    9/19/2025$84.00Overweight → Neutral
    Piper Sandler
    9/16/2025$95.00Outperform
    Wolfe Research
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    More analyst ratings

    $MET
    SEC Filings

    View All

    SEC Form 8-K filed by MetLife Inc.

    8-K - METLIFE INC (0001099219) (Filer)

    2/26/26 4:12:16 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form FWP filed by MetLife Inc.

    FWP - METLIFE INC (0001099219) (Subject)

    2/24/26 4:46:23 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form 8-K filed by MetLife Inc.

    8-K - METLIFE INC (0001099219) (Filer)

    2/24/26 4:21:13 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, U.S. Business Tadros Ramy was granted 42,916 shares and covered exercise/tax liability with 2,299 shares, increasing direct ownership by 22% to 221,985 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    2/26/26 4:36:42 PM ET
    $MET
    Life Insurance
    Finance

    Director Seitz Michelle was granted 273 units of Common Stock (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    2/26/26 4:36:36 PM ET
    $MET
    Life Insurance
    Finance

    EVP & Chief Risk Officer Debel Marlene covered exercise/tax liability with 5,624 shares and was granted 30,002 shares, increasing direct ownership by 18% to 158,513 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    2/26/26 4:36:30 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MetLife downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded MetLife from Outperform to In-line and set a new price target of $97.00

    1/6/26 8:46:59 AM ET
    $MET
    Life Insurance
    Finance

    Mizuho initiated coverage on MetLife with a new price target

    Mizuho initiated coverage of MetLife with a rating of Outperform and set a new price target of $101.00

    12/16/25 8:59:16 AM ET
    $MET
    Life Insurance
    Finance

    MetLife downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded MetLife from Overweight to Neutral and set a new price target of $84.00

    9/19/25 8:25:43 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    12/18/23 5:20:05 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AM Best Assigns Issue Credit Rating to MetLife, Inc.'s New Subordinated Debentures

    AM Best has assigned a Long-Term Issue Credit Rating of "bbb+" (Good) to the newly issued $1 billion, 5.85% subordinated debentures, due March 15, 2056, issued by MetLife, Inc. (MetLife) (headquartered in New York, NY) (NYSE:MET). The outlook assigned to this Credit Rating (rating) is stable. All other ratings of MetLife and its subsidiaries remain unchanged. The proceeds from this debt issuance are expected to be used to cover general business purposes. MetLife's proforma adjusted financial leverage and the historical interest coverage are in line with its current ratings, and its holding company liquidity is strong. This press release relates to Credit Ratings that have been published

    2/26/26 5:42:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Appoints Two Experienced Leaders to Board of Directors

    MetLife, Inc. (NYSE:MET) today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors (the "Board"), effective immediately. Both leaders bring significant leadership and business experience to their roles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224365562/en/MetLife today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors, effective immediately. Glaser, currently an operating partner at the private investment firm CD&R, has held senior positions in commercial insurance and insurance brokerage for more than 40 years, including serving for a decade as presiden

    2/24/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Executive to Speak at Raymond James 47th Annual Institutional Investors Conference

    MetLife, Inc. (NYSE:MET) today announced that Ramy Tadros, regional president of MetLife's U.S. Business and head of MetLife Holdings, will participate in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on Wednesday, March 4, 2026, beginning at 10:25 a.m. (ET). A live webcast of the presentation will be available over the internet at https://event.summitcast.com/view/VSr8zRPFYu9jT7Rm69ptdC/fnXahDQq5cAwNB3QpWHPxq. Those who want to listen should go to the website at least 15 minutes prior to the presentation to download and install any necessary software. A replay of the presentation will be available until Wednesday, March 11, 2026, at 11:59 p.m. (ET) a

    2/18/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Financials

    Live finance-specific insights

    View All

    MetLife Announces First Quarter 2026 Preferred Stock Dividend Actions

    Declares Series D, E and F Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of wh

    2/17/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Announces Full Year and 4Q 2025 Results

    MetLife, Inc. (NYSE:MET) today announced its full year and fourth quarter 2025 results. Earnings   Return   Per Share on Equity (ROE     4Q 2025   4Q 2025 Net Income $1.17 ROE 12.0%   Adjusted Earnings $2.49 Adjusted ROE 17.6% Full Year Results Net income was $3.2 billion, or $4.71 per share. Adjusted earnings per share, excluding total notable items, up 10%1 to $8.89. Premiums, fees and other revenues (PFOs) increased 10% to $57.6 billion. Adjusted PFOs, excluding pension risk transfers (PRT), were up 5% to $49.8 billion. RIS record sales,

    2/4/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife CFO John McCallion Provides Fourth Quarter and Full Year 2025 Financial Update Video

    MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided a fourth quarter and full year 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260204908797/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help in

    2/4/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Leadership Updates

    Live Leadership Updates

    View All

    MetLife Appoints Two Experienced Leaders to Board of Directors

    MetLife, Inc. (NYSE:MET) today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors (the "Board"), effective immediately. Both leaders bring significant leadership and business experience to their roles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224365562/en/MetLife today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors, effective immediately. Glaser, currently an operating partner at the private investment firm CD&R, has held senior positions in commercial insurance and insurance brokerage for more than 40 years, including serving for a decade as presiden

    2/24/26 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Investment Management Completes Acquisition of PineBridge Investments

    The combination brings together global scale and deep specialization, accelerating MetLife's growth in asset management MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), closed today on its acquisition of PineBridge Investments (PineBridge). The combined business manages $734.7 billion1 of assets, serving clients around the world. Accelerating growth in asset management is a top priority for MetLife in its New Frontier strategy. The acquisition brings together MIM's institutional strength and scale with PineBridge's global footprint and deep specialization to position MIM as a top-tier diversified global asset manager. "Toget

    12/30/25 5:15:00 AM ET
    $MET
    Life Insurance
    Finance

    MetLife and Global Citizen Announce Major Partnership to Drive Economic Change and Foster Resilient Communities

    MetLife Foundation Commits $9 Million to FIFA Global Citizen Education Fund Today at the 2025 Global Citizen Festival, MetLife, a leading financial services company providing insurance and employee benefits, proudly announced becoming a major partner with Global Citizen, the world's largest movement to end extreme poverty, with a new three-year partnership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250926660696/en/NEW YORK, NEW YORK - SEPTEMBER 27: (L-R) Michael Roberts and Nuria Garcia speak onstage during the 2025 Global Citizen Festival at Central Park on September 27, 2025 in New York City. (Photo by Noam Galai/Getty

    9/27/25 9:15:00 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    11/1/24 5:05:26 PM ET
    $MET
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    8/1/24 4:38:49 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form SC 13D/A filed by MetLife Inc. (Amendment)

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    5/2/24 5:34:57 PM ET
    $MET
    Life Insurance
    Finance